Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.
about
Promising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Ligand-based targeted therapy: a novel strategy for hepatocellular carcinomaDrug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of gliomaLipid vesicles containing transferrin receptor binding peptide TfR-T12 and octa-arginine conjugate stearyl-R8 efficiently treat brain glioma along with glioma stem cellsMedical treatment of orthotopic glioblastoma with transferrin-conjugated nanoparticles encapsulating zoledronic acidPLGA-PLL-PEG-Tf-based targeted nanoparticles drug delivery system enhance antitumor efficacy via intrinsic apoptosis pathway.Anti-ABCG2 scFv antibody of lung adenocarcinoma increases chemosensitivity and induces apoptosis through the activation of mitochondrial pathway.Identification of Tumor Antigen AF20 as Glycosylated Transferrin Receptor 1 in Complex with Heat Shock Protein 90 and/or Transporting ATPaseNew developments and controversies in iron metabolism and iron chelation therapy.Modular nanotransporters for targeted intracellular delivery of drugs: folate receptors as potential targets.Novel drug-delivery approaches to the blood-brain barrier.Rational, computer-enabled peptide drug design: principles, methods, applications and future directions.Transferrin-functionalized nanographene oxide for delivery of platinum complexes to enhance cancer-cell selectivity and apoptosis-inducing efficacy.Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.A ruthenium(ii) based photosensitizer and transferrin complexes enhance photo-physical properties, cell uptake, and photodynamic therapy safety and efficacy.Enhanced antitumor efficacy of cisplatin for treating ovarian cancer in vitro and in vivo via transferrin binding.Plasmid pORF-hTRAIL targeting to glioma using transferrin-modified polyamidoamine dendrimerTheranostics for hepatocellular carcinoma with Fe3O4@ZnO nanocomposites.Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis.Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1.Tackling breast cancer chemoresistance with nano-formulated siRNA.Tumor-targeted nanotherapeutics: overcoming treatment barriers for glioblastoma.Iron overload and altered iron metabolism in ovarian cancer.Cancer-Associated, Stimuli-Driven, Turn on Theranostics for Multimodality Imaging and Therapy.Post-Transcriptional Regulation of the GASC1 Oncogene with Active Tumor-Targeted siRNA-Nanoparticles.Combined sodium ion sensitivity in agonist binding and internalization of vasopressin V1b receptors.ATIQCTPC: a nanomedicine capable of targeting tumor and blocking thrombosis in vivo.Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value.Receptor Crosslinking in Drug Delivery: Detour to the Lysosome?Surface marker profiling of SH-SY5Y cells enables small molecule screens identifying BMP4 as a modulator of neuroblastoma differentiationBlocking transferrin receptor inhibits the growth of lung adenocarcinoma cells in vitro.Targeting Strategies for the Combination Treatment of Cancer Using Drug Delivery Systems.Novel PAMAM-PEG-Peptide Conjugates for siRNA Delivery Targeted to the Transferrin and Epidermal Growth Factor Receptors.Green and facile synthesis of a theranostic nanoprobe with intrinsic biosafety and targeting abilities.Targeted Therapeutic Nanoparticles: An Immense Promise to Fight against Cancer.PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan.Facile preparation of hyaluronic acid and transferrin co-modified Fe3O4 nanoparticles with inherent biocompatibility for dual-targeting magnetic resonance imaging of tumors in vivo.Development of bioactive materials for glioblastoma therapy.Bio-Inspired Protein-Based Nanoformulations for Cancer Theranostics.Responsive Contrast Agents: Synthesis and Characterization of a Tunable Series of pH-Sensitive Near-Infrared Pentamethines.
P2860
Q26778701-1ED89376-D841-4F9F-A03E-4A6EBDE829F4Q28068437-891832C9-51DB-4E96-A38C-D691D84DAB8BQ30413487-2E50C4C1-709D-4283-9410-B8D1E28BA939Q33799308-AFA2BB32-A3BE-4E14-83BB-82B9F59EF66BQ34786475-A588CBEB-590C-42C2-AA87-D51066ECCE05Q34982384-55CF4220-C53B-4D22-AADE-0A39155158ADQ36050053-F63BA2B9-E619-45BE-BEA4-3F37D6568EADQ36179308-9F799AF2-3DE6-4F96-9F3C-B42F39993117Q36719376-77606EE0-71EB-40C0-B79F-80C10D73116BQ38259956-26410F40-2918-434D-A82C-70DB2293B3E1Q38321195-56D81E30-359E-4827-9601-4D3DB322CACFQ38618616-2D33EBAF-BBA7-41FE-A572-5B3557FF0CBCQ38648996-2C24F13C-E3E5-4360-9F62-DA694CF954E3Q38694765-3E7C9959-99E0-4030-900A-A87ACDF9A997Q38788535-272CA25A-08C1-407F-8896-D91AC0AE2911Q38796925-10D06B32-CA9D-4CFC-8B18-BD28F6195FC5Q38807560-C9E474FA-7012-4CEB-98D4-F959EF033EE7Q38823021-1BD77631-1699-44A8-A740-876F17FB3F91Q38837337-999E5019-6BEA-444B-A0D0-413FA31246CCQ38847426-49C24361-9179-4406-86BF-36F687228E2AQ38959517-02E0077C-707A-4C48-A04C-0BF235A7D8DFQ38998571-4050F028-BE44-498C-8727-D4DE41010724Q39092091-A1E4DAFB-A4CD-4CDD-8317-0339F42166E4Q39216032-5F4A78D5-BBC5-477E-B3FB-6E900FBC03E0Q40736574-D749936C-9775-4F53-8EAE-5D2318907FA1Q40898155-9A87C6A0-36EF-4411-A409-5AAFCFC959F5Q41095538-E7E67D04-7977-4D51-9BD8-9A64B261FFEBQ41512201-17D1528C-4AF7-4B64-B1A7-007F2746207EQ42069859-77CE395A-C92D-4EEB-8616-2B03F6D2A0AEQ42670722-0B382693-236F-49EC-8DD0-2B1AFF00FC14Q47234596-1AC2803E-2469-45C2-AC15-6ED39743DC7DQ47440128-5ACE5FB2-966A-477D-B84A-CF8F6051DAFFQ48284313-3344DC63-F295-4141-BFD9-1AB99724B2E7Q49115686-FF8A5607-9156-4336-9887-17366B2F82C8Q49787181-B05CFFAD-9DB7-47A6-A13F-3B20790BC2AEQ50587758-F34972D9-663D-4E7D-A047-94584639F6D8Q50919320-1A80B0F3-35D8-4BE2-843C-97A6539844C3Q54955140-8E385894-3515-4E31-94D2-C63A6DF1B8D8Q55024462-07EFCAE5-7AD7-40D2-80F0-E4E80F20361EQ55664571-49CE0057-0E88-408A-B33A-464866CC5630
P2860
Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.
@en
type
label
Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.
@en
prefLabel
Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.
@en
P2860
P1476
Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.
@en
P2093
Stephanie Tortorella
Tom C Karagiannis
P2860
P2888
P304
P356
10.1007/S00232-014-9637-0
P577
2014-02-27T00:00:00Z
P6179
1036813772